CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 475 of 637 entries

View as:

A Safety and Immunogenicity Trial of IHV01

Phase: N/A Priority: Normal

NCT ID: NCT02756208 Org: User:

Start: 11/30/15 End: 07/31/18 Due: 07/31/19

Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.

Phase: N/A Priority: Normal

NCT ID: NCT02846740 Org: User:

Start: 03/01/17 End: 01/22/18 Due: 01/22/19

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal

NCT ID: NCT00004009 Org: User:

Start: 06/30/99 End: 04/30/01 Due: 04/30/02

Ultrasound vs Veinviewer in Patients With Difficulty IV Access

Phase: N/A Priority: Normal

NCT ID: NCT02618252 Org: User:

Start: 08/31/16 End: 12/31/25 Due: 12/31/26

Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation

Phase: N/A Priority: Normal

NCT ID: NCT03341156 Org: User:

Start: 07/11/18 End: 02/20/25 Due: 02/20/26

LITT Followed by Hypofractionated RT for Recurrent Gliomas

Phase: N/A Priority: Normal

NCT ID: NCT04181684 Org: User:

Start: 01/08/20 End: 12/31/26 Due: 12/31/27

RCT of a Polyherbal Dietary Supplement for Prediabetes

Phase: N/A Priority: Normal

NCT ID: NCT03388762 Org: User:

Start: 12/05/17 End: 01/01/20 Due: 01/01/21

Fitness and Longevity in Exercise

Phase: N/A Priority: Normal

NCT ID: NCT03399136 Org: User:

Start: 07/19/07 End: 04/23/12 Due: 04/23/13

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Phase: N/A Priority: Normal

NCT ID: NCT01531530 Org: User:

Start: 07/31/11 End: 09/30/12 Due: 09/30/13

MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043)

Phase: N/A Priority: Normal

NCT ID: NCT01768442 Org: User:

Start: 09/30/11 End: 01/31/19 Due: 01/31/20

1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02700776 Org: User:

Start: 04/30/14 End: 02/27/17 Due: 02/27/18

Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL

Phase: N/A Priority: Normal

NCT ID: NCT04827745 Org: User:

Start: 06/11/21 End: 08/01/27 Due: 08/01/28

Imaging With a Radio Tracer to Guide VT Ablations

Phase: N/A Priority: Normal

NCT ID: NCT01250912 Org: User:

Start: 03/31/10 End: 07/01/19 Due: 07/01/20

Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00925119 Org: User:

Start: 12/31/09 End: 05/31/14 Due: 05/31/15

Comparing Chemoprevention Drugs for School-based Malaria Control

Phase: N/A Priority: Normal

NCT ID: NCT05980156 Org: User:

Start: 02/13/23 End: 07/28/23 Due: 07/28/24

Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections

Phase: N/A Priority: Normal

NCT ID: NCT03098394 Org: User:

Start: 09/24/18 End: 06/20/23 Due: 06/20/24

Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use

Phase: N/A Priority: Normal

NCT ID: NCT01631383 Org: User:

Start: 10/31/12 End: 06/30/17 Due: 06/30/18

A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition

Phase: N/A Priority: Normal

NCT ID: NCT00525304 Org: User:

Start: 09/30/07 End: 05/31/15 Due: 05/31/16

Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use

Phase: N/A Priority: Normal

NCT ID: NCT05521880 Org: User:

Start: 07/15/24 End: 05/23/25 Due: 05/23/26

Pharmacokinetics of Antiepileptics in Patients on CRRT

Phase: N/A Priority: Normal

NCT ID: NCT03632915 Org: User:

Start: 11/20/17 End: 12/31/19 Due: 12/31/20

Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients

Phase: N/A Priority: Normal

NCT ID: NCT01433055 Org: User:

Start: 07/31/11 End: 01/31/14 Due: 01/31/15

Ocular Complications From Cancer Therapy - Patient Registry and Biobank

Phase: N/A Priority: Normal

NCT ID: NCT06874283 Org: User:

Start: 05/31/25 End: 04/30/31 Due: 04/30/32

Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)

Phase: N/A Priority: Normal

NCT ID: NCT01692743 Org: User:

Start: 09/30/12 End: 09/30/16 Due: 09/30/17

Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT01123317 Org: User:

Start: 07/31/10 End: 01/31/13 Due: 01/31/14

Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection

Phase: N/A Priority: Normal

NCT ID: NCT01129453 Org: User:

Start: 05/31/10 End: 04/30/13 Due: 04/30/14

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Safety and Immunogenicity Trial of IHV01	NCT02756208	University of Maryland, Baltimore	user2@example.com	None	2015-11-30	2018-07-31	2019-07-31	-	-	2025-07-14
Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.	NCT02846740	University of Maryland, Baltimore	user2@example.com	None	2017-03-01	2018-01-22	2019-01-22	-	-	2025-07-14
R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia	NCT00004009	University of Maryland, Baltimore	user2@example.com	None	1999-06-30	2001-04-30	2002-04-30	-	-	2025-07-14
Ultrasound vs Veinviewer in Patients With Difficulty IV Access	NCT02618252	University of Maryland, Baltimore	user2@example.com	None	2016-08-31	2025-12-31	2026-12-31	-	-	2025-07-14
Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation	NCT03341156	University of Maryland, Baltimore	user2@example.com	None	2018-07-11	2025-02-20	2026-02-20	-	-	2025-07-14
LITT Followed by Hypofractionated RT for Recurrent Gliomas	NCT04181684	University of Maryland, Baltimore	user2@example.com	None	2020-01-08	2026-12-31	2027-12-31	-	-	2025-07-14
RCT of a Polyherbal Dietary Supplement for Prediabetes	NCT03388762	University of Maryland, Baltimore	user2@example.com	None	2017-12-05	2020-01-01	2021-01-01	-	-	2025-07-14
Fitness and Longevity in Exercise	NCT03399136	University of Maryland, Baltimore	user2@example.com	None	2007-07-19	2012-04-23	2013-04-23	-	-	2025-07-14
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP	NCT01531530	University of Maryland, Baltimore	user2@example.com	None	2011-07-31	2012-09-30	2013-09-30	-	-	2025-07-14
MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043)	NCT01768442	University of Maryland, Baltimore	user2@example.com	None	2011-09-30	2019-01-31	2020-01-31	-	-	2025-07-14
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer	NCT02700776	University of Maryland, Baltimore	user2@example.com	None	2014-04-30	2017-02-27	2018-02-27	-	-	2025-07-14
Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL	NCT04827745	University of Maryland, Baltimore	user2@example.com	None	2021-06-11	2027-08-01	2028-08-01	-	-	2025-07-14
Imaging With a Radio Tracer to Guide VT Ablations	NCT01250912	University of Maryland, Baltimore	user2@example.com	None	2010-03-31	2019-07-01	2020-07-01	-	-	2025-07-14
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes	NCT00925119	University of Maryland, Baltimore	user2@example.com	None	2009-12-31	2014-05-31	2015-05-31	-	-	2025-07-14
Comparing Chemoprevention Drugs for School-based Malaria Control	NCT05980156	University of Maryland, Baltimore	user2@example.com	None	2023-02-13	2023-07-28	2024-07-28	-	-	2025-07-14
Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections	NCT03098394	University of Maryland, Baltimore	user2@example.com	None	2018-09-24	2023-06-20	2024-06-20	-	-	2025-07-14
Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use	NCT01631383	University of Maryland, Baltimore	user2@example.com	None	2012-10-31	2017-06-30	2018-06-30	-	-	2025-07-14
A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition	NCT00525304	University of Maryland, Baltimore	user2@example.com	None	2007-09-30	2015-05-31	2016-05-31	-	-	2025-07-14
Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use	NCT05521880	University of Maryland, Baltimore	user2@example.com	None	2024-07-15	2025-05-23	2026-05-23	-	-	2025-07-14
Pharmacokinetics of Antiepileptics in Patients on CRRT	NCT03632915	University of Maryland, Baltimore	user2@example.com	None	2017-11-20	2019-12-31	2020-12-31	-	-	2025-07-14
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients	NCT01433055	University of Maryland, Baltimore	user2@example.com	None	2011-07-31	2014-01-31	2015-01-31	-	-	2025-07-14
Ocular Complications From Cancer Therapy - Patient Registry and Biobank	NCT06874283	University of Maryland, Baltimore	user2@example.com	None	2025-05-31	2031-04-30	2032-04-30	-	-	2025-07-14
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)	NCT01692743	University of Maryland, Baltimore	user2@example.com	None	2012-09-30	2016-09-30	2017-09-30	-	-	2025-07-14
Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia	NCT01123317	University of Maryland, Baltimore	user2@example.com	None	2010-07-31	2013-01-31	2014-01-31	-	-	2025-07-14
Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection	NCT01129453	University of Maryland, Baltimore	user2@example.com	None	2010-05-31	2013-04-30	2014-04-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance